Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

BACKGROUND Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci (MAPT and SNCA) to risk of Parkinson's disease. We aimed to identify novel risk loci for Parkinson's disease. METHODS We did a meta-analysis of datasets from five Parkinson's disease GWAS from the USA and Europe to identify loci associated with Parkinson's disease (discovery phase). We then did replication analyses of significantly associated loci in an independent sample series. Estimates of population-attributable risk were calculated from estimates from the discovery and replication phases combined, and risk-profile estimates for loci identified in the discovery phase were calculated. FINDINGS The discovery phase consisted of 5333 case and 12 019 control samples, with genotyped and imputed data at 7 689 524 SNPs. The replication phase consisted of 7053 case and 9007 control samples. We identified 11 loci that surpassed the threshold for genome-wide significance (p<5×10(-8)). Six were previously identified loci (MAPT, SNCA, HLA-DRB5, BST1, GAK and LRRK2) and five were newly identified loci (ACMSD, STK39, MCCC1/LAMP3, SYT11, and CCDC62/HIP1R). The combined population-attributable risk was 60·3% (95% CI 43·7-69·3). In the risk-profile analysis, the odds ratio in the highest quintile of disease risk was 2·51 (95% CI 2·23-2·83) compared with 1·00 in the lowest quintile of disease risk. INTERPRETATION These data provide an insight into the genetics of Parkinson's disease and the molecular cause of the disease and could provide future targets for therapies. FUNDING Wellcome Trust, National Institute on Aging, and US Department of Defense.

[1]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[2]  Sanjiv J. Shah,et al.  Whole-genome association study identifies STK39 as a hypertension susceptibility gene , 2009, Proceedings of the National Academy of Sciences.

[3]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[4]  Luigi Ferrucci,et al.  Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain , 2010, PLoS genetics.

[5]  Matti Pirinen,et al.  Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21 , 2010, Human molecular genetics.

[6]  J. Roder,et al.  Huntingtin-Interacting Protein 1 Influences Worm and Mouse Presynaptic Function and Protects Caenorhabditis elegans Neurons against Mutant Polyglutamine Toxicity , 2007, The Journal of Neuroscience.

[7]  Eden R Martin,et al.  Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.

[8]  J. Stockman.  Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .

[9]  S. Pulst,et al.  The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. , 2003, Human molecular genetics.

[10]  S. Pulst,et al.  Screening for mutations in synaptotagmin XI in Parkinson's disease. , 2004, Journal of neural transmission. Supplementum.

[11]  Sreeram V Ramagopalan,et al.  Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility , 2009, Proceedings of the National Academy of Sciences.

[12]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[13]  K. Sirotkin,et al.  The NCBI dbGaP database of genotypes and phenotypes , 2007, Nature Genetics.

[14]  A. Boyles,et al.  National Institute of Environmental Health Sciences , 2008 .

[15]  J. Nutt,et al.  Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease , 2010, Nature Genetics.

[16]  A. Laslop,et al.  Dense-core granules: a specific hallmark of the neuronal/neurosecretory cell phenotype , 2004, Journal of Cell Science.

[17]  Mohamad Saad,et al.  Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. , 2011, Human molecular genetics.

[18]  D. Hernandez,et al.  Genome-wide association study confirms extant PD risk loci among the Dutch , 2011, European Journal of Human Genetics.

[19]  C. Watson,et al.  The Effect of Single Nucleotide Polymorphisms from Genome Wide Association Studies in Multiple Sclerosis on Gene Expression , 2010, PloS one.

[20]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[21]  G. Abecasis,et al.  Genotype imputation. , 2009, Annual review of genomics and human genetics.

[22]  Harriet Noreen,et al.  Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. , 2007, Human immunology.

[23]  M. Rizzi,et al.  The crystal structure of human α‐amino‐β‐carboxymuconate‐ε‐semialdehyde decarboxylase in complex with 1,3‐dihydroxyacetonephosphate suggests a regulatory link between NAD synthesis and glycolysis , 2009, The FEBS journal.

[24]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[25]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[26]  B. Keavney,et al.  STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression , 2009, BMC Medical Genetics.

[27]  A. Singleton,et al.  Towards a complete resolution of the genetic architecture of disease. , 2010, Trends in genetics : TIG.

[28]  Evangelos Evangelou,et al.  Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations , 2007, PloS one.

[29]  A. Sidhu,et al.  An Inflammatory Pathomechanism for Parkinsons Disease , 2006 .

[30]  J. Pritchard,et al.  Overcoming the winner's curse: estimating penetrance parameters from case-control data. , 2007, American journal of human genetics.

[31]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[32]  J. Buxbaum,et al.  An analysis of candidate autism loci on chromosome 2q24–q33: Evidence for association to the STK39 gene , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[33]  A. Singleton,et al.  Parkinson's disease and dementia with Lewy bodies: a difference in dose? , 2004, The Lancet.